(Q50860920)

English

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study.

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study. (English)

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

0 references

DNA methylation

0 references

metastatic breast cancer

1 reference

based on heuristic

inferred from title

Antonio C. Wolff

18

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

Anna Maria V. Storniolo

12

object named as

Anna M Storniolo

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

16

object named as

James N Ingle

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

14

object named as

Nancy U Lin

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

author name string

Kala Visvanathan

1

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

MaryJo S Fackler

2

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

Zhe Zhang

3

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

Zoila A Lopez-Bujanda

4

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

Stacie C Jeter

5

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

Lori J Sokoll

6

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

Elizabeth Garrett-Mayer

7

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

Leslie M Cope

8

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

Christopher B Umbricht

9

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

David M Euhus

10

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

Andres Forero

11

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

Rita Nanda

13

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

Lisa A Carey

15

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

Saraswati Sukumar

17

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

language of work or name

0 references

publication date

21 November 2016

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

Journal of Clinical Oncology

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

35

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

7

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

751-758

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

22 May 2018

Circulating tumor DNA as an early marker of therapeutic response in patients with metastatic colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

22 May 2018

Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

22 May 2018

Clinical utility of certain biomarkers as predictors of breast cancer with or without metastasis among Egyptian females

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

22 May 2018

Methylated DNA and high total DNA levels in the serum of patients with breast cancer following neoadjuvant chemotherapy are predictive of a poor prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

22 May 2018

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

22 May 2018

Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

22 May 2018

Chromatin and DNA replication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

22 May 2018

Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

22 May 2018

Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

22 May 2018

RASSF1A: Not a prototypical Ras effector.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

22 May 2018

Hypermethylated genes as biomarkers of cancer in women with pathologic nipple discharge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

22 May 2018

The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

22 May 2018

A Ras-induced conformational switch in the Ras activator Son of sevenless

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

22 May 2018

Use of biomarkers in epidemiologic studies: minimizing the influence of measurement error in the study design and analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

22 May 2018

The measurement and therapeutic implications of circulating tumour cells in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

22 May 2018

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

22 May 2018

Epigenetics in human disease and prospects for epigenetic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

22 May 2018

A simulation study of cross-validation for selecting an optimal cutpoint in univariate survival analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

22 May 2018

Circulating tumor DNA to monitor metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

14 August 2018

CST6 promoter methylation in circulating cell-free DNA of breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

14 August 2018

Recent reports about enzymes related to the synthesis of prostaglandin (PG) F(2) (PGF(2α) and 9α, 11β-PGF(2)).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

14 August 2018

Prognostic significance of methylated RASSF1A and PITX2 genes in blood- and bone marrow plasma of breast cancer patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

14 August 2018

Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

14 August 2018

Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

14 August 2018

Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

14 August 2018

DNA methylation and epigenetic mechanisms of carcinogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5455421

14 August 2018

DNA methylation and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/27870562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR

1 reference

https://pubmed.ncbi.nlm.nih.gov/27870562

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2015.66.2080

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

24 March 2018

http://europepmc.org/abstract/PMC/5455421

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50860920&oldid=1872244475"